Aisling Capital Management LP
14 holdingsFiling period: 2026-06-30Current AUM: $390.1Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | BBIO | Bridgebio Pharma Inc | 4.59M | $341.8M | $310.0M | 79.46% | -500,000 | 2026-06-30 |
| 2 | GLUE | Monte Rosa Therapeutics Inc | 1.56M | $37.6M | $17.7M | 4.53% | -- | 2026-06-30 |
| 3 | SNDX | Syndax Pharmaceuticals Inc | 1.32M | $28.8M | $17.4M | 4.47% | -- | 2026-06-30 |
| 4 | CMPS | Compass Pathways PLC | 1.43M | $20.3M | $17.0M | 4.37% | -- | 2026-06-30 |
| 5 | BCAX | Bicara Therapeutics Inc | 568.9K | $16.9M | $10.4M | 2.68% | -- | 2026-06-30 |
| 6 | BBOT | Bridgebio Oncology Therapeut | 1.02M | $7.8M | $2.8M | 0.71% | -- | 2026-06-30 |
| 7 | SRRK | Scholar Rock Hldg Corp | 77.0K | $4.2M | $3.2M | 0.82% | -- | 2026-06-30 |
| 8 | — | Urogen Pharma Ltd | 108.0K | $4.0M | $4.0M | 1.02% | -- | 2026-06-30 |
| 9 | BMEA | Biomea Fusion Inc | 2.05M | $3.0M | $1.5M | 0.39% | -- | 2026-06-30 |
| 10 | ACRS | Aclaris Therapeutics Inc | 434.5K | $2.3M | $1.6M | 0.42% | -- | 2026-06-30 |
| 11 | EPRX | Eupraxia Pharmaceuticals Inc | 325.0K | $2.1M | $2.5M | 0.63% | -- | 2026-06-30 |
| 12 | VTVT | Vtv Therapeutics Inc | 50.0K | $1.9M | $1.4M | 0.36% | -- | 2026-06-30 |
| 13 | MRKR | Marker Therapeutics Inc | 325.4K | $478K | $377K | 0.10% | -- | 2026-06-30 |
| 14 | OKUR | Onkure Therapeutics Inc | 88.6K | $404K | $209K | 0.05% | -- | 2026-06-30 |
← Scroll →